These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 15221157)

  • 21. Primary prevention of ulcers in patients taking aspirin or NSAIDs.
    Med Lett Drugs Ther; 2010 Mar; 52(1333):17-9. PubMed ID: 20300052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does famotidine have similar efficacy to misoprostol in the treatment of non-steroidal anti-inflammatory drug-induced gastropathy?
    Wu CS; Wang SH; Chen PC; Wu VC
    Int J Clin Pract; 1998 Oct; 52(7):472-4. PubMed ID: 10622088
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastroprotective agents for the prevention of NSAID-induced gastropathy.
    Ares JJ; Outt PE
    Curr Pharm Des; 1998 Feb; 4(1):17-36. PubMed ID: 10197031
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention of NSAID-induced ulcers in the elderly.
    Geriatrics; 2005 Oct; Suppl():3-12; quiz 13-4. PubMed ID: 16334635
    [No Abstract]   [Full Text] [Related]  

  • 25. Risk of peptic ulcer hospitalizations in users of NSAIDs with gastroprotective cotherapy versus coxibs.
    Ray WA; Chung CP; Stein CM; Smalley WE; Hall K; Arbogast PG; Griffin MR
    Gastroenterology; 2007 Sep; 133(3):790-8. PubMed ID: 17854591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Indications for anti-ulcer drugs in adults].
    Chassany O
    Presse Med; 2000 Jan; 29(2):94-7. PubMed ID: 10682038
    [No Abstract]   [Full Text] [Related]  

  • 27. Non-steroidal anti-inflammatory drug prescribing patterns in general practice: comparison of a general practitioner-based survey and a pharmacy-based survey in France.
    Clinard F; Sgro C; Bardou M; Dumas M; Hillon P; Bonithon-Kopp C
    Pharmacoepidemiol Drug Saf; 2001; 10(4):329-38. PubMed ID: 11760495
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Primary care research needs to be strengthened].
    Vega Cubillo E; García Sánchez JA; García Ortega P; Carvajal A
    Aten Primaria; 2002; 30(3):191. PubMed ID: 12139862
    [No Abstract]   [Full Text] [Related]  

  • 29. Use of gastroprotection in patients discharged from hospital on nonsteroidal anti-inflammatory drugs.
    Coté GA; Norvell JP; Rice JP; Bulsiewicz WJ; Howden CW
    Am J Ther; 2008; 15(5):444-9. PubMed ID: 18806520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention and management of NSAID-induced ulcers.
    Graham JA
    Am Pharm; 1992 Dec; NS32(12):62-4. PubMed ID: 1363026
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonsteroidal anti-inflammatory drugs (NSAIDs), cyxlooxygenase-2 selective inhibitors (coxibs) and gastrointestinal harm: review of clinical trials and clinical practice.
    Moore RA; Derry S; Phillips CJ; McQuay HJ
    BMC Musculoskelet Disord; 2006 Oct; 7():79. PubMed ID: 17054784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dyspepsia in non-steroidal anti-inflammatory drug users and the effect of preventive measures.
    Lee HL; Chua SS; Mahadeva S
    J Dig Dis; 2018 Jun; 19(6):342-349. PubMed ID: 29732728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prescription audit of NSAIDs and gastroprotective strategy in elderly in primary care.
    Al Khaja KAJ; Veeramuthu S; Isa HA; Sequeira RP
    Int J Risk Saf Med; 2017; 29(1-2):57-68. PubMed ID: 28885223
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gastroprotective drugs in Australia: utilization patterns between 1997 and 2006 in relation to NSAID prescribing.
    Barozzi N; Tett SE
    Clin Ther; 2009 Apr; 31(4):849-61. PubMed ID: 19446158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is NSAIDs-related gastrointestinal damage preventable?
    Gargallo CJ; Lanas A
    J Dig Dis; 2013 Feb; 14(2):55-61. PubMed ID: 23216831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prescription of and adherence to non-steroidal anti-inflammatory drugs and gastroprotective agents in at-risk gastrointestinal patients.
    Lanas A; Polo-Tomás M; Roncales P; Gonzalez MA; Zapardiel J
    Am J Gastroenterol; 2012 May; 107(5):707-14. PubMed ID: 22334248
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Prophylaxis and therapy of gastropathy caused by non-steroidal anti-inflammatory drugs].
    László A
    Orv Hetil; 2002 Jul; 143(27):1643-8. PubMed ID: 12180001
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.